2m 2m 2m 2m 2m 2m 2m
GAIN THERAPEUTIC (GANX)
NASDAQ
$1.83+$0.04 (+2.12%)
Price as of Jun 03, 2026 6:08 PM EDT- $83.2MMarket Cap
- -10.05%1-Year Change
- BiotechnologyIndustry
GAIN THERAPEUTIC (GANX)
$1.83+$0.04 (+2.12%)
GANX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.79 | ||
Change | -$0.04 (-2.19%) | ||
Open | $1.83 | ||
High | $1.84 | ||
Low | $1.76 | ||
Previous Close | $1.83 | ||
Volume | 374,689 | ||
30-Day Average Volume | 651,249 | ||
1-Week Change | 1.13% | ||
1-Month Change | -4.79% | ||
1-Year Change | -10.05% | ||
3-Year Change | -63.69% | ||
5-Year Change | -82.62% | ||
Fundamentals | |||
Shares Outstanding | 42.7M | ||
Total Assets | $18.7M | ||
Market Cap | $83.2M | ||
Enterprise Value | $67.0M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$5.6M | ||
Free Cash Flow | -$4.7M | ||
EBIT | -$5.4M | ||
EBITDA | -$5.4M | ||
Net Working Capital | $14.3M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -15 | ||
PEG | 2 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue